Chargement en cours...

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

Dementia due to Alzheimer’s disease (AD) is estimated to reach epidemic proportions by the year 2030. Given the limited accuracy of current AD clinical diagnosis, biomarkers of AD pathologies are currently being sought. Reductions in cerebrospinal fluid levels of β-amyloid 42 (a marker of amyloid pl...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fagan, Anne M, Perrin, Richard J
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477809/
https://ncbi.nlm.nih.gov/pubmed/22917147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm.12.42
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!